358 related articles for article (PubMed ID: 18929111)
1. The management of exfoliative glaucoma.
Ritch R
Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
[TBL] [Abstract][Full Text] [Related]
2. Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.
Angelilli A; Ritch R
Middle East Afr J Ophthalmol; 2009 Jan; 16(1):35-40. PubMed ID: 20142958
[TBL] [Abstract][Full Text] [Related]
3. From epidemiology to lysyl oxidase like one (LOXL1) polymorphisms discovery: phenotyping and genotyping exfoliation syndrome and exfoliation glaucoma in Iceland.
Jonasson F
Acta Ophthalmol; 2009 Aug; 87(5):478-87. PubMed ID: 19664108
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
5. Association of LOXL1 gene with Finnish exfoliation syndrome patients.
Lemmelä S; Forsman E; Onkamo P; Nurmi H; Laivuori H; Kivelä T; Puska P; Heger M; Eriksson A; Forsius H; Järvelä I
J Hum Genet; 2009 May; 54(5):289-97. PubMed ID: 19343041
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
7. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
Thorleifsson G; Magnusson KP; Sulem P; Walters GB; Gudbjartsson DF; Stefansson H; Jonsson T; Jonasdottir A; Jonasdottir A; Stefansdottir G; Masson G; Hardarson GA; Petursson H; Arnarsson A; Motallebipour M; Wallerman O; Wadelius C; Gulcher JR; Thorsteinsdottir U; Kong A; Jonasson F; Stefansson K
Science; 2007 Sep; 317(5843):1397-400. PubMed ID: 17690259
[TBL] [Abstract][Full Text] [Related]
8. [Relevance of the pseudoexfoliation syndrome for the glaucomas].
Schlötzer-Schrehardt U; Küchle M; Jünemann A; Naumann GO
Ophthalmologe; 2002 Sep; 99(9):683-90. PubMed ID: 12219256
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
[TBL] [Abstract][Full Text] [Related]
10. The LOXL1 gene variations are not associated with primary open-angle and primary angle-closure glaucomas.
Chakrabarti S; Rao KN; Kaur I; Parikh RS; Mandal AK; Chandrasekhar G; Thomas R
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2343-7. PubMed ID: 18223248
[TBL] [Abstract][Full Text] [Related]
11. Exfoliation syndrome.
Ritch R; Schlötzer-Schrehardt U
Surv Ophthalmol; 2001; 45(4):265-315. PubMed ID: 11166342
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous, bilateral intraocular lens dislocation in a patient with exfoliation syndrome.
Rutner D; Madonna RJ
Optometry; 2007 May; 78(5):220-4. PubMed ID: 17478339
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression in pseudoexfoliation syndrome.
Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
[TBL] [Abstract][Full Text] [Related]
14. LOXL1 gene sequence variants and vascular disease in exfoliation syndrome and exfoliative glaucoma.
Holló G; Gál A; Kóthy P; Molnár JM
J Glaucoma; 2011 Mar; 20(3):143-7. PubMed ID: 20436359
[TBL] [Abstract][Full Text] [Related]
15. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
16. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
[TBL] [Abstract][Full Text] [Related]
17. [Pseudoexfoliation syndrome--etiopatogenesis and clinical course].
Ludwisiak-Kocerba L; Hevelke A; Kecik D
Klin Oczna; 2006; 108(1-3):82-6. PubMed ID: 16883948
[TBL] [Abstract][Full Text] [Related]
18. Ocular and systemic manifestations of exfoliation syndrome.
Ritch R
J Glaucoma; 2014; 23(8 Suppl 1):S1-8. PubMed ID: 25275896
[TBL] [Abstract][Full Text] [Related]
19. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
Schlötzer-Schrehardt U; Zenkel M
Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
Zenkel M
J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
